These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11838626)

  • 21. Attitude towards antipsychotics among out-patients with schizophrenia in Nigeria.
    Adewuya AO; Ola BA; Mosaku SK; Fatoye FO; Eegunranti AB
    Acta Psychiatr Scand; 2006 Mar; 113(3):207-11. PubMed ID: 16466404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study.
    Bobes J; Arango C; Garcia-Garcia M; Rejas J;
    J Clin Psychiatry; 2010 Mar; 71(3):280-6. PubMed ID: 19895779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment adherence and insight in schizophrenia.
    Bitter I; Fehér L; Tényi T; Czobor P
    Psychiatr Hung; 2015; 30(1):18-26. PubMed ID: 25867885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of paliperidone extended release on subjective well-being and responses in patients with schizophrenia.
    Kim SW; Yoon JS; Kim YS; Ahn YM; Kim CE; Go HJ; Chee IS; Jung SW; Chung YC; Kim YD; Joe S; Lee J; Kwon YJ; Yoon BH; Jae YM
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug; 38(2):228-35. PubMed ID: 22516251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence.
    Lambert M; Conus P; Eide P; Mass R; Karow A; Moritz S; Golks D; Naber D
    Eur Psychiatry; 2004 Nov; 19(7):415-22. PubMed ID: 15504648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of antipsychotic side effects on attitudes towards medication in people with schizophrenia and related disorders.
    Chiang YL; Klainin-Yobas P; Ignacio J; Chng CM
    J Clin Nurs; 2011 Aug; 20(15-16):2172-82. PubMed ID: 21539628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment compliance of outpatients with schizophrenia: patient's attitudes, demographic, clinical and therapeutic variables.
    Stanković Z; Britvić D; Vuković O; Ille T
    Psychiatr Danub; 2008 Mar; 20(1):42-52. PubMed ID: 18376330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Factors related to treatment adherence in schizophrenic patients].
    García Cabeza I; Sánchez Díaz EI; Sanz Amador M; Gutiérrez Rodríguez M; González de Chávez M
    Actas Esp Psiquiatr; 1999; 27(4):211-6. PubMed ID: 10469940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of subjective treatment satisfaction with antipsychotics in schizophrenia patients.
    Fujikawa M; Togo T; Yoshimi A; Fujita J; Nomoto M; Kamijo A; Amagai T; Uchikado H; Katsuse O; Hosojima H; Sakura Y; Furusho R; Suda A; Yamaguchi T; Hori T; Kamada A; Kondo T; Ito M; Odawara T; Hirayasu Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):755-60. PubMed ID: 18226436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Relationships between insight and medication adherence in subjects with psychosis].
    Droulout T; Liraud F; Verdoux H
    Encephale; 2003; 29(5):430-7. PubMed ID: 14615692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between attitude toward medication and neurocognitive function in schizophrenia.
    Kim SW; Shin IS; Kim JM; Yang SJ; Shin HY; Yoon JS
    Clin Neuropharmacol; 2006; 29(4):197-205. PubMed ID: 16855421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subjective illness theory and antipsychotic medication compliance by patients with schizophrenia.
    Holzinger A; Loffler W; Muller P; Priebe S; Angermeyer MC
    J Nerv Ment Dis; 2002 Sep; 190(9):597-603. PubMed ID: 12357093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals.
    Day JC; Bentall RP; Roberts C; Randall F; Rogers A; Cattell D; Healy D; Rae P; Power C
    Arch Gen Psychiatry; 2005 Jul; 62(7):717-24. PubMed ID: 15997012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Are we addressing the 'right stuff' to enhance adherence in schizophrenia? Understanding the role of insight and attitudes towards medication.
    Beck EM; Cavelti M; Kvrgic S; Kleim B; Vauth R
    Schizophr Res; 2011 Oct; 132(1):42-9. PubMed ID: 21820875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of Antipsychotic Dose Reduction in Late-Life Schizophrenia: A Prospective Dopamine D2/3 Receptor Occupancy Study.
    Graff-Guerrero A; Rajji TK; Mulsant BH; Nakajima S; Caravaggio F; Suzuki T; Uchida H; Gerretsen P; Mar W; Pollock BG; Mamo DC
    JAMA Psychiatry; 2015 Sep; 72(9):927-34. PubMed ID: 26131622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Attitudes toward menstruation in females with schizophrenia or schizoaffective disorders in Taiwan.
    Liang HY; Lee LW; Kelsen BA; Hsu SC; Liu CY; Chen CY
    Climacteric; 2013 Dec; 16(6):682-8. PubMed ID: 23205628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Subjective perception of the effect of neuroleptics by outpatient schizophrenic patients: a cross-sectional study].
    Bonsack C; Conus P; Philippoz R; Bovet J; Spagnoli J; Dufour H
    Encephale; 1998; 24(4):315-23. PubMed ID: 9809236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The interaction of subjective experience and attitudes towards specific antipsychotic-related adverse effects in schizophrenia patients.
    Fischel T; Krivoy A; Kotlarov M; Zemishlany Z; Loebstein O; Jacoby H; Weizman A
    Eur Psychiatry; 2013 Aug; 28(6):340-3. PubMed ID: 22999435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fewer symptoms vs. more side-effects in schizophrenia? Opposing pathways between antipsychotic medication compliance and quality of life.
    Staring AB; Mulder CL; Duivenvoorden HJ; De Haan L; Van der Gaag M
    Schizophr Res; 2009 Aug; 113(1):27-33. PubMed ID: 19525092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reasons for adherence and nonadherence: a pilot study comparing first- and multi-episode schizophrenia patients.
    Sapra M; Weiden PJ; Schooler NR; Sunakawa-McMillan A; Uzenoff S; Burkholder P
    Clin Schizophr Relat Psychoses; 2014 Jan; 7(4):199-206. PubMed ID: 23428784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.